BBIO
BridgeBio Pharma, Inc. Common Stock ·
—
Market cap
—
52-week range
—
Volume
—
Previous close
—
BridgeBio Pharma, Inc. Common Stock (BBIO) is held by 8 tracked hedge fund(s). Largest tracked holder: Kohlberg Kravis Roberts & Co. L.P..
| Fund | % of portfolio | Shares | Value | Latest activity | Avg buy price | Date |
|---|---|---|---|---|---|---|
| Kohlberg Kravis Roberts & Co. L.P. Kohlberg Kravis Roberts & Co. L.P. |
18.4% | 13.3M | $985M | — | $16.58 | 2026-03-31 |
| VIKING GLOBAL INVESTORS LP Andreas Halvorsen |
2.5% | 11.8M | $879M | ▼ 18% (−2.6M) | $16.58 | 2026-03-31 |
| Polar Capital Holdings Plc Polar Capital Holdings Plc |
0.7% | 2.5M | $187M | ▲ 94% (+1.2M) | $65.85 | 2026-03-31 |
| SC US (TTGP), LTD. SC US (TTGP), LTD. |
1.5% | 1.9M | $138M | — | $16.58 | 2026-03-31 |
| Hood River Capital Management LLC Hood River Capital Management LLC |
0.9% | 1.3M | $94M | ▲ 0.8% (+10K) | $52.34 | 2026-03-31 |
| Driehaus Capital Management LLC Driehaus Capital Management LLC |
0.6% | 1.1M | $85M | ▼ 32% (−534K) | $36.00 | 2026-03-31 |
| FRONTIER CAPITAL MANAGEMENT CO LLC FRONTIER CAPITAL MANAGEMENT CO LLC |
0.7% | 958K | $71M | ▲ 16% (+132K) | $45.48 | 2026-03-31 |
| Deep Track Capital, LP Deep Track Capital, LP |
1.0% | 841K | $62M | ▲ 3.9% (+31K) | $38.72 | 2026-03-31 |
Related ▾
FAQ ▾
Which hedge funds hold BBIO?
Tracked holders include: Kohlberg Kravis Roberts & Co. L.P., VIKING GLOBAL INVESTORS LP, Polar Capital Holdings Plc, SC US (TTGP), LTD..
How much smart money owns BBIO?
8 tracked hedge fund(s) have disclosed positions.
Are members of Congress trading BBIO?
No tracked Congressional trades in BBIO on file.
Where does this data come from?
SEC 13F filings (funds), Form 4 (insiders) and STOCK Act reports (Congress).
Sourced from SEC 13F, Form 4 & STOCK Act filings · Not investment advice ▾
Ownership from SEC filings; price from market data.
Published by WealthFile · Not investment advice.